CSRxP: Weight Loss Drugs the Latest Target for Big Pharma’s Price-Gouging of American Patients
Aug 24, 2023
Analysis Finds Brand Name Drug Makers Setting U.S. Prices for Obesity… Read More
© 2025 CSRXP- All Rights Reserved
Press Release
CSRxP Poll: Voters Overwhelmingly Reject Big Pharma’s Bogus Blame Game, Support Market-Based Solutions to Lower Rx Prices by Holding Big Pharma Accountable
Aug 16, 2023
Americans from Across the Political Spectrum Want Congress to Pass Bipartisan… Read More
CSRXP: ANALYSIS FINDS 200 PERCENT INCREASE IN SECONDARY PATENT FILINGS AS BIG PHARMA EXPLOITS LOOPHOLES TO BLOCK COMPETITION
Aug 9, 2023
Over 15 Year Period, Brand Name Drug Companies Increasingly Filed for… Read More
CSRXP: BIG PHARMA INCREASES PRICES ON MORE THAN 100 BRAND NAME DRUGS IN LATEST PRICE HIKING BINGE
Jul 18, 2023
Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to… Read More
CSRXP: PROPOSAL TO LOOSEN PATENT RULES WOULD FURTHER EMPOWER BIG PHARMA TO BLOCK COMPETITION
Jun 23, 2023
Lawmakers Should Focus on Bipartisan Solutions to Hold Big Pharma Accountable,… Read More
CSRXP: SENATORS HAVE OPPORTUNITY TO PASS BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
May 11, 2023
U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and… Read More
CSRXP: MODERNA BRAZENLY IGNORES OUTRAGE BY MOVING AHEAD WITH EGREGIOUS VACCINE PRICE HIKE
May 4, 2023
Nearly 500 Percent Price Increase on Vaccine Developed with Taxpayer… Read More
CSRXP APPLAUDS REINTRODUCTION OF FAIR DRUG PRICING ACT
Mar 24, 2023
Bipartisan Transparency Legislation Will Help Hold Big Pharma Accountable for… Read More
CSRXP: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE FOR UNCONSCIONABLE PRICE HIKES ON COVID-19 VACCINES AND TREATMENTS
Mar 22, 2023
Senate HELP Committee Hearing with Moderna CEO Offers Prime Opportunity to… Read More
CSRXP STATEMENT ON ELI LILLY ANNOUNCEMENT ON PRICE OF INSULIN PRODUCTS
Mar 1, 2023
More Big Pharma Companies Should Also Lower Their Insulin Prices… Read More
CSRXP APPLAUDS SENATORS FOR BIPARTISAN ACTION TO HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS PATENT ABUSE
Feb 9, 2023
Senate Judiciary Committee Advances Critical Legislation to Crack Down on… Read More
CSRXP APPLAUDS POSITIVE PROGRESS, ENCOURAGES POLICYMAKERS TO ADVANCE ADDITIONAL MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
Feb 8, 2023
Policies Must Address Big Pharma’s Egregious Practices That Cause High Drug… Read More